Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients

por Malingré, M M, Beijnen, J H, Rosing, H, Koopman, F J, Jewell, R C, Paul, E M, Huinink, W W Ten Bokkel, Schellens, J H M
Publicado 2001

The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients

por Malingré, M M, Schellens, J H M, Tellingen, O Van, Ouwehand, M, Bardelmeijer, H A, Rosing, H, Koopman, F J, Schot, M E, Huinink, W W Ten Bokkel, Beijnen, J H
Publicado 2001